COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 1415: Articles 14141-14150  | Next

Temporal trends in primary care-recorded self-harm during and beyond the first year of the COVID-19 pandemic: time series analysis of electronic healthcare records for 2.8 million patients in the Greater Manchester Care Record
Steeg, S., Bojanic, L., Tilston, G., Williams, R., Jenkins, D. A., Carr, M. J., Peek, N., Ashcroft, D. M., Kapur, N., Voorhees, J., Webb, R. T.
10.1101/2021.06.23.21259400 — Posted: 2021-06-30
Thrombocytopenia and splenic platelet directed immune responses after intravenous ChAdOx1 nCov-19 administration
Nicolai, L., Leunig, A., Pekayvaz, K., Anjum, A., Riedlinger, E., Eivers, L., Hoffknecht, M.-L., Rossaro, D., Escaig, R., Kaiser, R., Polewka, V., Titova, A., Spiekermann, K., Iannacone, M., Stark, K., Massberg, S.
10.1101/2021.06.29.450356 — Posted: 2021-06-29
Genetic diversity and evolution of SARS-CoV-2 in Belgium during the first wave outbreak
Wawina-Bokalanga, T., Marti-Carreras, J., Vanmechelen, B., Bloemen, M., Wollants, E., Laenen, L., Cuypers, L., Beuselinck, K., Lagrou, K., Andre, E., Van Ranst, M., Maes, P.
10.1101/2021.06.29.450330 — Posted: 2021-06-29
Absolute quantitation of individual SARS-CoV-2 RNA molecules: a new paradigm for infection dynamics and variant differences
Lee, J. Y., Wing, P. A., Gala, D. S., Jarvelin, A. I., Titlow, J., Noerenberg, M., Zhuang, X., Johnson, N., Iselin, L., Thompson, M. K., Parton, R. M., Wainman, A., Agranoff, D., James, W., Castello, A., McKeating, J. A., Davis, I.
10.1101/2021.06.29.450133 — Posted: 2021-06-29
Natural isolate and recombinant SARS-CoV-2 rapidly evolve in vitro to higher infectivity through more efficient binding to heparan sulfate and reduced S1/S2 cleavage
Shiliaev, N., Lukash, T., Palchevska, O., Crossman, D. K., Green, T. J., Crowley, M., Frolova, E. I., Frolov, I.
10.1101/2021.06.28.450274 — Posted: 2021-06-29
Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
Cerutti, G., Guo, Y., Wang, P., Nair, M. S., Huang, Y., Yu, J., Liu, L., Katsamba, P. S., Bahna, F., Reddem, E. R., Kwong, P. D., Ho, D. D., Sheng, Z., Shapiro, L.
10.1101/2021.06.29.450397 — Posted: 2021-06-29
Rapid determination of the wide dynamic range of SARS-CoV-2 Spike T cell responses in whole blood of vaccinated and naturally infected
Tan, A. T., Lim, J. M., Le Bert, N., Kunasegaran, K., Chia, A., Qui, M., Tan, N., Chia, W. N., Alwis, R., Ding, Y., Ooi, E. E., Wang, L.-F., Chen, M. I., Young, B., Hsu, L. Y., Low, J., Lye, D., Bertoletti, A.
10.1101/2021.06.29.450293 — Posted: 2021-06-29
Systematic genome-scale identification of host factors for SARS-CoV-2 infection across models yields a core single gene dependency; ACE2
Chan, K., Farias, A. G., Lee, H., Guvenc, F., Mero, P., Aulakh, K., Brown, K. R., Haider, S., Marcon, E., Braunschweig, U., Tong, A. H. Y., Pu, S., Habsid, A., Christie-Holmes, N., Budylowski, P., Astori, A., Ghalami, A., Mubareka, S., Banerjee, A., Mossman, K. L., Greenblatt, J., Gray-Owen, S. D., Raught, B., Blencowe, B., Taiplale, M., Moffat, J.
10.1101/2021.06.28.450244 — Posted: 2021-06-29
Assessment of COVID-19 vaccine hesitancy among Zimbabweans: A rapid national survey
Mundagowa, P. T., Tozivepi, S. N., Chiyaka, E. T., Mukora-Mutseyekwa, F., Makurumidze, R.
10.1101/2021.06.24.21259505 — Posted: 2021-06-29
Japanese Project for Telepsychiatry Evaluation during COVID-19: Treatment Comparison Trial (J-PROTECT): Rationale, design, and methodology
Kishimoto, T., Kinoshita, S., Bun, S., Sato, Y., Kitazawa, M., Kikuchi, T., Sado, M., Takamiya, A., Mimura, M., Nakamae, T., Abe, Y., Kanazawa, T., Kawabata, Y., Tomita, H., Abe, K., Hishimoto, A., Asami, T., Suda, A., Watanabe, Y., Amagai, T., Sakuma, K., Kida, H., Funayama, M., Kimura, H., Sato, A., Fujiwara, S., Nagao, K., Sugiyama, N., Takamiya, M., Kodama, H., Azekawa, T.
10.1101/2021.06.23.21259366 — Posted: 2021-06-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).